Manufacturing Collaboration MediciNova is coordinating manufacturing requirements with Kissei, presenting opportunities for contract development and manufacturing organizations to support scalable GMP production, process development, and API supply as they advance clinical programs.

ALS Trial Partnerships With a late stage ALS program and ongoing trial updates, there is potential to engage CROs, patient recruitment networks, data management providers, and sites to accelerate trial execution and regulatory milestones.

Regulatory Readiness The addition of a Clinical and Regulatory Advisor indicates ongoing regulatory strategy needs, offering a path for regulatory affairs consultants to assist in strategy, submissions planning, and interactions with health authorities across key markets.

Strategic Partnerships Participation in investor events and award recognitions signal openness to external partnerships, licensing deals, or co-development opportunities with pharma companies and academic collaborators.

Market Access Readiness As a global biopharma with modest revenue and a lean team, MediciNova could benefit from market access and commercialization services to prepare for future launches, payer engagement, and regional commercialization across markets.